BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19027282)

  • 21. Proliferative Potential of Cardiomyocytes in Hypertrophic Cardiomyopathy: Correlation with Myocardial Remodeling.
    Sukhacheva TV; Chudinovskikh YA; Eremeeva MV; Serov RA; Bockeria LA
    Bull Exp Biol Med; 2016 Nov; 162(1):160-169. PubMed ID: 27882462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium reintroduction decreases viability of cardiac myocytes from copper-deficient rats.
    Prohaska JR; Heller LJ
    J Nutr; 1999 Oct; 129(10):1842-5. PubMed ID: 10498756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survivin determines cardiac function by controlling total cardiomyocyte number.
    Levkau B; Schäfers M; Wohlschlaeger J; von Wnuck Lipinski K; Keul P; Hermann S; Kawaguchi N; Kirchhof P; Fabritz L; Stypmann J; Stegger L; Flögel U; Schrader J; Fischer JW; Hsieh P; Ou YL; Mehrhof F; Tiemann K; Ghanem A; Matus M; Neumann J; Heusch G; Schmid KW; Conway EM; Baba HA
    Circulation; 2008 Mar; 117(12):1583-93. PubMed ID: 18332262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
    Karpanen T; Bry M; Ollila HM; Seppänen-Laakso T; Liimatta E; Leskinen H; Kivelä R; Helkamaa T; Merentie M; Jeltsch M; Paavonen K; Andersson LC; Mervaala E; Hassinen IE; Ylä-Herttuala S; Oresic M; Alitalo K
    Circ Res; 2008 Oct; 103(9):1018-26. PubMed ID: 18757827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female rats are susceptible to cardiac hypertrophy induced by copper deficiency: the lack of influence of estrogen and testosterone.
    Farquharson C; Robins SP
    Proc Soc Exp Biol Med; 1988 Jul; 188(3):272-81. PubMed ID: 2969110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of coenzyme Q10 supplementation on cardiac hypertrophy of male rats consuming a high-fructose, low-copper diet.
    Lewis CG; Fields M; Burns WA; Lure MD
    Biol Trace Elem Res; 1993; 37(2-3):137-49. PubMed ID: 7688527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue.
    Tiburcy M; Didié M; Boy O; Christalla P; Döker S; Naito H; Karikkineth BC; El-Armouche A; Grimm M; Nose M; Eschenhagen T; Zieseniss A; Katschinksi DM; Hamdani N; Linke WA; Yin X; Mayr M; Zimmermann WH
    Circ Res; 2011 Oct; 109(10):1105-14. PubMed ID: 21921264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart?
    Porrello ER; Widdop RE; Delbridge LM
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1358-64. PubMed ID: 18759854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
    Wei X; Wu B; Zhao J; Zeng Z; Xuan W; Cao S; Huang X; Asakura M; Xu D; Bin J; Kitakaze M; Liao Y
    Circulation; 2015 Apr; 131(17):1506-17; discussion 1517. PubMed ID: 25820336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair.
    Lorts A; Schwanekamp JA; Elrod JW; Sargent MA; Molkentin JD
    Circ Res; 2009 Jan; 104(1):e1-7. PubMed ID: 19038863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interconnection of parameters of the mitochondrial and myofibrillar apparatus of cardiomyocytes and ploidy and hypertrophy in certain mammalian species, differing in body mass].
    Kudriavtsev BN; Anatskaia OV; Nilova VK; Komarov SA
    Tsitologiia; 1997; 39(10):946-64. PubMed ID: 9505342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cardiomyocyte cell cycle in hypertrophy, tissue homeostasis, and regeneration.
    Zebrowski DC; Engel FB
    Rev Physiol Biochem Pharmacol; 2013; 165():67-96. PubMed ID: 23605180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
    Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
    Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
    J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.
    Guo R; Liu N; Liu H; Zhang J; Zhang H; Wang Y; Baruscotti M; Zhao L; Wang Y
    Phytomedicine; 2020 Mar; 68():153171. PubMed ID: 32018211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.